International Biotechnology Trust PLC Macrogenics Inc Transaction History

International Biotechnology Trust PLC

  • $295 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$14.51 - $19.71 $275,690 - $374,490
-19,000 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$11.11 - $25.6 $211,090 - $486,400
19,000 New
19,000 $342,000
Q3 2017

Mar 02, 2018
SELL
$15.52 - $18.94 $838,080 - $1.02 Million
-54,000 Closed
0 $0
Q4 2016

Mar 02, 2018
BUY
N/A
54,000
54,000 $1.1 Million

Others Institutions Holding MGNX

# of Institutions
111
Shares Held
50M
Call Options Held
65.5K
Put Options Held
93.9K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $94.6M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email